Helio Genomics Email Format
Biotechnology ResearchCalifornia, United States51-200 Employees
Helio Genomics is a biotechnology research company focused on detecting cancer early from a simple blood draw. It pursues an integrated approach that blends multiple types of biological data to illuminate how cancer exists and evolves, with the aim of guiding medical decision-making. The company is headquartered in Irvine, California, with additional offices in Indiana, and it maintains collaborations with researchers and clinicians in the United States and China. It operates CLIA and CAP certified laboratories, collaborates with third-party testing partners, and runs cGMP facilities to support its work. In 2026 it announced a strategic commercial partnership with Syneos Health to broaden access to its cancer-detection offerings.